Ishiki, Aiko
Tohoku Medical and Pharmaceutical University
8 papers on CoChat
Most cited papers
- Verified
18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
Harada, R., Okamura, N., Furumoto, S., Furukawa, K., Ishiki, A., Tomita, N., Tago, T., Hiraoka, K., Watanuki, S., Shidahara, M., et al. (2016) · Journal of Nuclear Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 330
- Verified
Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease
Harada, R., Ishiki, A., Kai, H., Sato, N., Furukawa, K., Furumoto, S., Tago, T., Tomita, N., Watanuki, S., Hiraoka, K., et al. (2018) · Journal of Nuclear Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 168
- Verified
Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer’s disease, dementia with Lewy bodies, and frontotemporal lobar degeneration
Ishiki, A., Kamada, M., Kawamura, Y., Terao, C., Shimoda, F., Tomita, N., Arai, H., & Furukawa, K. (2016) · Journal of Neurochemistry
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 156
- Verified
Tau imaging with [18F]THK‐5351 in progressive supranuclear palsy
Ishiki, A., Harada, R., Okamura, N., Tomita, N., Rowe, C. C., Villemagne, V. L., Yanai, K., Kudo, Y., Arai, H., Furumoto, S., et al. (2017) · European Journal of Neurology
Alzheimer's disease research and treatmentsParkinson's Disease Mechanisms and Treatments
Cited by 92
- Verified
[18F]‐THK5351 PET correlates with topology and symptom severity in progressive supranuclear palsy
Brendel, M., Schönecker, S., Höglinger, G., Lindner, S., Havla, J., Blautzik, J., Sauerbeck, J., Rohrer, G., Zach, C., Vettermann, F., et al. (2018) · Frontiers in Aging Neuroscience
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 72
- Verified
A Pilot Study of Whole-Brain Low-Intensity Pulsed Ultrasound Therapy for Early Stage of Alzheimer’s Disease (LIPUS-AD): A Randomized, Double-Blind, Placebo-Controlled Trial
Shimokawa, H., Shindo, T., Ishiki, A., Tomita, N., Ichijyo, S., Watanabe, T., Nakata, T., Eguchi, K., Kikuchi, Y., Shiroto, T., et al. (2022) · The Tohoku Journal of Experimental Medicine
Ultrasound and Hyperthermia ApplicationsAlzheimer's disease research and treatments
Cited by 51
- Verified
Pivotal trial of low-intensity pulsed ultrasound therapy for early Alzheimer's disease: Rationale and design
Shimokawa, H., Akishita, M., Ihara, M., Teramukai, S., Ishiki, A., Nagai, Y., & Fukushima, M. (2025) · Journal of Alzheimer's Disease Reports
Alzheimer's disease research and treatmentsUltrasound and Hyperthermia Applications
Cited by 3
- Verified
Baseline characteristics of patients with early Alzheimer's disease enrolled in the pivotal trial of low-intensity pulsed ultrasound (LIPUS-AD)
Shimokawa, H., Akishita, M., Asada, T., Katayama, S., Hattori, Y., Yakushiji, Y., Taki, Y., Murai, H., Boku, Y., Tsujimoto, M., et al. (2025) · Journal of Alzheimer's Disease Reports
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 0
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free